BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18022700)

  • 1. Multiple sclerosis patients show sexual dimorphism in cytokine responses to myelin antigens.
    Moldovan IR; Cotleur AC; Zamor N; Butler RS; Pelfrey CM
    J Neuroimmunol; 2008 Jan; 193(1-2):161-9. PubMed ID: 18022700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.
    Hellings N; Barée M; Verhoeven C; D'hooghe MB; Medaer R; Bernard CC; Raus J; Stinissen P
    J Neurosci Res; 2001 Feb; 63(3):290-302. PubMed ID: 11170179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in cytokine responses to myelin peptides in multiple sclerosis.
    Pelfrey CM; Cotleur AC; Lee JC; Rudick RA
    J Neuroimmunol; 2002 Sep; 130(1-2):211-23. PubMed ID: 12225904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotype.
    Dhib-Jalbut S; Chen M; Said A; Zhan M; Johnson KP; Martin R
    J Neuroimmunol; 2003 Jul; 140(1-2):163-71. PubMed ID: 12864985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls.
    Minohara M; Ochi H; Matsushita S; Irie A; Nishimura Y; Kira J
    Tissue Antigens; 2001 May; 57(5):447-56. PubMed ID: 11556969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals.
    Tejada-Simon MV; Hong J; Rivera VM; Zhang JZ
    Eur J Immunol; 2001 Mar; 31(3):907-17. PubMed ID: 11241296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis: association with clinical and MRI activity.
    Hellings N; Gelin G; Medaer R; Bruckers L; Palmers Y; Raus J; Stinissen P
    J Neuroimmunol; 2002 May; 126(1-2):143-60. PubMed ID: 12020966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.
    Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA
    J Clin Invest; 1996 Jul; 98(1):70-7. PubMed ID: 8690806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.
    Kerlero de Rosbo N; Milo R; Lees MB; Burger D; Bernard CC; Ben-Nun A
    J Clin Invest; 1993 Dec; 92(6):2602-8. PubMed ID: 7504688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon gamma responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression.
    Moldovan IR; Rudick RA; Cotleur AC; Born SE; Lee JC; Karafa MT; Pelfrey CM
    J Neuroimmunol; 2003 Aug; 141(1-2):132-40. PubMed ID: 12965264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoreactivity to myelin antigens related to HLA associations with multiple sclerosis.
    Yentür SP; Akman-Demir G; Eraksoy M; Saruhan-Direskeneli G
    Mult Scler; 2002 Aug; 8(4):278-83. PubMed ID: 12166496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elispot assay detection of cytokine secretion in multiple sclerosis patients treated with interferon-beta1a or glatiramer acetate compared with untreated patients.
    Jansson A; Ernerudh J; Kvarnström M; Ekerfelt C; Vrethem M
    Mult Scler; 2003 Oct; 9(5):440-5. PubMed ID: 14582766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
    Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA
    J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal single-cell cytokine responses reveal recurrent autoimmune myelin reactivity in relapsing--remitting multiple sclerosis patients.
    Moldovan IR; Rudick RA; Cotleur AC; Born SE; Lee JC; Karafa MT; Pelfrey CM
    Mult Scler; 2005 Jun; 11(3):251-60. PubMed ID: 15957503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen.
    Diaz-Villoslada P; Shih A; Shao L; Genain CP; Hauser SL
    J Neuroimmunol; 1999 Sep; 99(1):36-43. PubMed ID: 10496175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production.
    Pelfrey CM; Rudick RA; Cotleur AC; Lee JC; Tary-Lehmann M; Lehmann PV
    J Immunol; 2000 Aug; 165(3):1641-51. PubMed ID: 10903775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response to myelin oligodendrocyte glycoprotein and myelin basic protein depend on familial background and are partially associated with human leukocyte antigen alleles in multiplex families and sporadic multiple sclerosis.
    Lutterotti A; Reindl M; Gassner C; Poustka K; Schanda K; Deisenhammer F; Berger T
    J Neuroimmunol; 2002 Oct; 131(1-2):201-7. PubMed ID: 12458053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant forms of myelin antigens expressed on Chinese hamster ovary (CHO) cells as a tool for identification of autoantibodies in serum of multiple sclerosis patients.
    Jaśkiewicz E; Michałowska-Wender G; Pyszczek A; Wender M
    Folia Neuropathol; 2010; 48(1):45-8. PubMed ID: 20383810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis.
    Johnson D; Hafler DA; Fallis RJ; Lees MB; Brady RO; Quarles RH; Weiner HL
    J Neuroimmunol; 1986 Nov; 13(1):99-108. PubMed ID: 2428837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis.
    Wallström E; Khademi M; Andersson M; Weissert R; Linington C; Olsson T
    Eur J Immunol; 1998 Oct; 28(10):3329-35. PubMed ID: 9808202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.